Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - ZYGO CORPFinancial_Report.xls
XML - IDEA: XBRL DOCUMENT - ZYGO CORPR9.htm
XML - IDEA: XBRL DOCUMENT - ZYGO CORPR8.htm
XML - IDEA: XBRL DOCUMENT - ZYGO CORPR4.htm
XML - IDEA: XBRL DOCUMENT - ZYGO CORPR7.htm
XML - IDEA: XBRL DOCUMENT - ZYGO CORPR2.htm
XML - IDEA: XBRL DOCUMENT - ZYGO CORPR3.htm
XML - IDEA: XBRL DOCUMENT - ZYGO CORPR6.htm
XML - IDEA: XBRL DOCUMENT - ZYGO CORPR5.htm
XML - IDEA: XBRL DOCUMENT - ZYGO CORPR1.htm
XML - IDEA: XBRL DOCUMENT - ZYGO CORPR17.htm
XML - IDEA: XBRL DOCUMENT - ZYGO CORPR25.htm
XML - IDEA: XBRL DOCUMENT - ZYGO CORPR24.htm
XML - IDEA: XBRL DOCUMENT - ZYGO CORPR13.htm
XML - IDEA: XBRL DOCUMENT - ZYGO CORPR16.htm
XML - IDEA: XBRL DOCUMENT - ZYGO CORPR12.htm
XML - IDEA: XBRL DOCUMENT - ZYGO CORPR21.htm
XML - IDEA: XBRL DOCUMENT - ZYGO CORPR15.htm
XML - IDEA: XBRL DOCUMENT - ZYGO CORPR14.htm
XML - IDEA: XBRL DOCUMENT - ZYGO CORPR19.htm
XML - IDEA: XBRL DOCUMENT - ZYGO CORPR23.htm
XML - IDEA: XBRL DOCUMENT - ZYGO CORPR20.htm
XML - IDEA: XBRL DOCUMENT - ZYGO CORPR22.htm
XML - IDEA: XBRL DOCUMENT - ZYGO CORPR18.htm
XML - IDEA: XBRL DOCUMENT - ZYGO CORPR10.htm
EX-31.2 - ZYGO CORPc69613_ex31-2.htm
EX-32.1 - ZYGO CORPc69613_ex32-1.htm
EX-31.1 - ZYGO CORPc69613_ex31-1.htm
EX-32.2 - ZYGO CORPc69613_ex32-2.htm
XML - IDEA: XBRL DOCUMENT - ZYGO CORPR11.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

(Mark One)

 

 

x

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

For the quarterly period ended March 31, 2012

 

 

or

 

o

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________________ to ___________________

Commission File Number 0-12944

 

ZYGO CORPORATION


(Exact name of registrant as specified in its charter)


 

 

 

Delaware

06-0864500

 




(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

 

 

 

 

Laurel Brook Road, Middlefield, Connecticut

06455

 




(Address of principal executive offices)

(Zip Code)

 


 

(860) 347-8506


Registrant’s telephone number, including area code

 

N/A


(Former name, former address, and former fiscal year, if changed from last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.                           x YES o NO

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).                x YES o NO

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer o

Accelerated filer x

 

 

Non-accelerated filer o (Do not check if a smaller reporting company)

Smaller reporting company o


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
o YES x NO

APPLICABLE ONLY TO CORPORATE ISSUERS:

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

18,195,977 shares of Common Stock, $.10 Par Value, at May 1, 2012

1


FORWARD LOOKING STATEMENTS

All statements other than statements of historical fact included in this Form 10-Q Quarterly Report regarding financial performance, condition and operations, and the business strategy, plans, anticipated revenues, bookings, market acceptance, growth rates, market opportunities, and objectives of management of the Company for future operations are forward-looking statements. Forward-looking statements provide management’s current expectations or plans for the future operating and financial performance of the Company based upon information currently available and assumptions currently believed to be valid. Forward-looking statements can be identified by the use of words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “plan(s),” “strategy,” “project,” “should” and other words of similar meaning in connection with a discussion of future operating or financial performance. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors. Among the important factors that could cause actual events to differ materially from those in the forward-looking statements are fluctuations in capital spending of our customers; fluctuations in revenues to our major customers; manufacturing and supplier risks; risks of booking cancellations, push-outs and de-bookings; dependence on timing and market acceptance of new product developments; rapid technological and market change; risks in international operations; risks related to the reorganization of our business; dependence on proprietary technology and key personnel; length of the revenue cycle; environmental regulations; investment portfolio returns; fluctuations in our stock price; the risk that anticipated growth opportunities may be smaller than anticipated or may not be realized; risks related to business acquisitions, including the acquisition of substantially all the assets of ASML US, Inc.’s Richmond, California facility and integration of the business and employees; the risks related to the Company’s recent changes in senior management; and the risks associated with the recovery from last year’s earthquake, tsunami and nuclear disaster in Japan and their impact on our customers, suppliers and operations.

Any forward-looking statements included in this Quarterly Report speak only as of the date of this document. We undertake no obligation to publicly update or revise forward-looking statements to reflect events or circumstances after the date of this Form 10-Q except as required by law. Further information on potential factors that could affect our business is described in this Form 10-Q and in our reports on file with the Securities and Exchange Commission, including our Form 10-K for the fiscal year ended June 30, 2011, filed with the Securities and Exchange Commission on September 13, 2011.

2


PART I - Financial Information

Item 1. Financial Statements

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
(Thousands, except per share amounts)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended
March 31,

 

Nine Months Ended
March 31,

 

 

 


 


 

 

 

2012

 

2011

 

2012

 

2011

 

 

 


 


 


 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net revenues

 

$

38,472

 

$

40,235

 

$

122,504

 

$

107,440

 

Cost of goods sold

 

 

19,032

 

 

21,371

 

 

61,805

 

 

57,479

 

 

 



 



 



 



 

Gross profit

 

 

19,440

 

 

18,864

 

 

60,699

 

 

49,961

 

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

 

8,702

 

 

9,418

 

 

26,272

 

 

24,886

 

Research, development and engineering expenses

 

 

4,017

 

 

3,739

 

 

12,166

 

 

10,872

 

 

 



 



 



 



 

Operating profit

 

 

6,721

 

 

5,707

 

 

22,261

 

 

14,203

 

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income (expense)

 

 

 

 

 

 

 

 

 

 

 

 

 

Gain on acquisition

 

 

 

 

 

 

 

 

1,289

 

Miscellaneous income (expense), net

 

 

(23

)

 

(153

)

 

(221

)

 

71

 

 

 



 



 



 



 

Total other income (expense)

 

 

(23

)

 

(153

)

 

(221

)

 

1,360

 

 

 



 



 



 



 

Earnings from continuing operations before income taxes, including noncontrolling interests

 

 

6,698

 

 

5,554

 

 

22,040

 

 

15,563

 

Income tax expense

 

 

(772

)

 

(720

)

 

(2,381

)

 

(1,474

)

 

 



 



 



 



 

Net earnings from continuing operations

 

 

5,926

 

 

4,834

 

 

19,659

 

 

14,089

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net earnings from discontinued operations, net of tax

 

 

 

 

 

 

 

 

91

 

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net earnings including noncontrolling interests

 

 

5,926

 

 

4,834

 

 

19,659

 

 

14,180

 

Less: Net earnings attributable to noncontrolling interests

 

 

519

 

 

361

 

 

1,605

 

 

1,205

 

 

 



 



 



 



 

Net earnings attributable to Zygo Corporation

 

$

5,407

 

$

4,473

 

$

18,054

 

$

12,975

 

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic       - Earnings per share attributable to Zygo Corporation

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

0.30

 

$

0.25

 

$

1.01

 

$

0.73

 

Discontinued operations

 

 

 

 

 

 

 

 

0.01

 

 

 



 



 



 



 

Net earnings per share

 

$

0.30

 

$

0.25

 

$

1.01

 

$

0.74

 

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted - Earnings per share attributable to Zygo Corporation

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

0.29

 

$

0.24

 

$

0.97

 

$

0.71

 

Discontinued operations

 

 

 

 

 

 

 

 

0.01

 

 

 



 



 



 



 

Net earnings per share

 

$

0.29

 

$

0.24

 

$

0.97

 

$

0.72

 

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic shares

 

 

18,116

 

 

17,693

 

 

17,948

 

 

17,600

 

 

 



 



 



 



 

Diluted shares

 

 

18,883

 

 

18,304

 

 

18,640

 

 

18,056

 

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amounts Attributable to Zygo Corporation

 

 

 

 

 

 

 

 

 

 

 

 

 

Net earnings from continuing operations attributable to Zygo Corporation

 

$

5,407

 

$

4,473

 

$

18,054

 

$

12,884

 

Discontinued operations, net of tax

 

 

 

 

 

 

 

 

91

 

 

 



 



 



 



 

Net earnings attributable to Zygo Corporation

 

$

5,407

 

$

4,473

 

$

18,054

 

$

12,975

 

 

 



 



 



 



 

See accompanying notes to condensed consolidated financial statements.

3


CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
(Thousands, except share amounts)

 

 

 

 

 

 

 

 

 

 

March 31, 2012

 

June 30, 2011

 

 

 


 


 

Assets

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

89,300

 

$

60,039

 

Marketable securities

 

 

 

 

1,000

 

Receivables, net of allowance for doubtful accounts of $908 and $1,399, respectively

 

 

23,456

 

 

31,424

 

Inventories

 

 

27,648

 

 

28,379

 

Prepaid expenses and other

 

 

2,076

 

 

1,745

 

 

 



 



 

Total current assets

 

 

142,480

 

 

122,587

 

 

 

 

 

 

 

 

 

Marketable securities

 

 

818

 

 

980

 

Property, plant and equipment, net

 

 

28,918

 

 

30,195

 

Intangible assets, net

 

 

5,393

 

 

5,842

 

 

 



 



 

Total assets

 

$

177,609

 

$

159,604

 

 

 



 



 

 

 

 

 

 

 

 

 

Liabilities and Equity

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

Accounts payable

 

$

8,215

 

$

7,120

 

Progress payments, deferred revenue and billings in excess of costs and estimated earnings

 

 

4,382

 

 

4,706

 

Accrued salaries and wages

 

 

5,653

 

 

8,636

 

Other accrued liabilities

 

 

6,383

 

 

6,093

 

Income taxes payable

 

 

26

 

 

550

 

Current liabilities of discontinued operations

 

 

 

 

281

 

 

 



 



 

Total current liabilities

 

 

24,659

 

 

27,386

 

 

 

 

 

 

 

 

 

Other long-term liabilities

 

 

2,590

 

 

4,131

 

 

 



 



 

Total Liabilities

 

 

27,249

 

 

31,517

 

 

 



 



 

 

 

 

 

 

 

 

 

Commitments and contingencies Equity:

 

 

 

 

 

 

 

Common stock, $0.10 par value per share:

 

 

 

 

 

 

 

40,000,000 shares authorized;

 

 

 

 

 

 

 

20,435,327 shares issued (19,985,631 at June 30, 2011);

 

 

 

 

 

 

 

18,176,979 shares outstanding (17,763,346 at June 30, 2011)

 

 

2,044

 

 

1,999

 

Additional paid-in capital

 

 

174,832

 

 

168,662

 

Accumulated deficit

 

 

(2,711

)

 

(20,765

)

Accumulated other comprehensive income:

 

 

 

 

 

 

 

Currency translation effects

 

 

349

 

 

1,197

 

Treasury stock, at cost, 2,258,348 shares (2,222,285 at June 30, 2011)

 

 

(26,775

)

 

(26,373

)

 

 



 



 

Total stockholders’ equity - Zygo Corporation

 

 

147,739

 

 

124,720

 

Noncontrolling interests

 

 

2,621

 

 

3,367

 

 

 



 



 

Total equity

 

 

150,360

 

 

128,087

 

 

 



 



 

Total liabilities and equity

 

$

177,609

 

$

159,604

 

 

 



 



 

See accompanying notes to condensed consolidated financial statements.

4


CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
(Thousands)

 

 

 

 

 

 

 

 

 

 

Nine Months Ended March 31,

 

 

 


 

 

 

2012

 

2011

 

 

 


 


 

Cash provided by operating activities:

 

 

 

 

 

 

 

Net earnings including noncontrolling interests

 

$

19,659

 

$

14,180

 

Adjustments to reconcile net earnings to cash provided by operating activities from continuing operations:

 

 

 

 

 

 

 

Earnings from discontinued operations

 

 

 

 

(91

)

Depreciation and amortization

 

 

4,292

 

 

4,718

 

Gain on acquisition, net of tax

 

 

 

 

(1,289

)

Deferred income taxes

 

 

 

 

(725

)

Provision for doubtful accounts

 

 

(360

)

 

(365

)

Compensation cost related to share-based payment arrangements

 

 

3,332

 

 

2,962

 

Excess tax benefits from share-based payment arrangements

 

 

(445

)

 

(28

)

Other

 

 

314

 

 

(360

)

Changes in operating accounts:

 

 

 

 

 

 

 

Receivables

 

 

8,031

 

 

(9,903

)

Inventories

 

 

742

 

 

321

 

Prepaid expenses and other current assets

 

 

(425

)

 

1,471

 

Accounts payable, accrued expenses and taxes payable

 

 

(4,039

)

 

1,904

 

 

 



 



 

Net cash provided by operating activities from continuing operations

 

 

31,101

 

 

12,795

 

 

 



 



 

Net cash used for operating activities from discontinued operations

 

 

(281

)

 

(263

)

 

 



 



 

Cash used for investing activities:

 

 

 

 

 

 

 

Additions to property, plant and equipment

 

 

(2,515

)

 

(1,025

)

Purchase of marketable securities

 

 

(999

)

 

(1,998

)

Additions to intangibles

 

 

(209

)

 

(427

)

Acquisitions

 

 

 

 

(7,142

)

Proceeds from the sale and maturity of marketable securities

 

 

2,127

 

 

2,089

 

Proceeds from the sale of other assets

 

 

 

 

62

 

 

 



 



 

Net cash used for investing activities

 

 

(1,596

)

 

(8,441

)

 

 



 



 

Cash provided by financing activities:

 

 

 

 

 

 

 

Dividend payment to noncontrolling interest

 

 

(2,192

)

 

(823

)

Excess tax benefits from share-based payment arrangements

 

 

445

 

 

28

 

Repurchase of restricted stock

 

 

(401

)

 

(285

)

Exercise of employee stock options

 

 

2,882

 

 

1,498

 

 

 



 



 

Net cash provided by financing activities

 

 

734

 

 

418

 

 

 



 



 

Effect of exchange rate changes on cash and cash equivalents

 

 

(697

)

 

1,296

 

 

 



 



 

Net increase in cash and cash equivalents

 

 

29,261

 

 

5,805

 

Cash and cash equivalents, beginning of period

 

 

60,039

 

 

46,536

 

 

 



 



 

Cash and cash equivalents, end of period

 

$

89,300

 

$

52,341

 

 

 



 



 

Supplemental Cash Flow Information

Net cash paid for income taxes was $2,860 for the nine months ended March 31, 2012. Net cash paid for income taxes was $361 for the nine months ended March 31, 2011.

See accompanying notes to condensed consolidated financial statements.

5


NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(Thousands, except share and per share amounts)

Note 1: Accounting Policies

Basis of Presentation and Principles of Consolidation
Zygo Corporation is a worldwide supplier of optical metrology instruments, precision optics, and electro-optical design and manufacturing services, serving customers in the semiconductor capital equipment, research, defense, life sciences and industrial markets. The accompanying condensed consolidated financial statements include the accounts of Zygo Corporation and its subsidiaries (“Zygo,” “we,” “us,” “our” or “the Company”). The Company follows accounting principles generally accepted in the United States of America (“US GAAP”). Zygo’s reporting currency is the U.S. dollar. The functional currency of the majority of our foreign subsidiaries is their local currency and, as such, amounts included in the condensed consolidated statements of operations are translated at the weighted-average exchange rates for the period. Assets and liabilities are translated at period-end exchange rates, and resulting foreign exchange translation adjustments are recorded in the consolidated balance sheets as a component of accumulated other comprehensive income. All transactions and accounts with the subsidiaries are eliminated from the condensed consolidated financial statements. The results of operations for the three and nine months ended March 31, 2012 are not necessarily indicative of the results to be expected for the full fiscal year.

The condensed consolidated balance sheet at March 31, 2012, the condensed consolidated statements of operations for the three and nine months ended March 31, 2012 and 2011, and the condensed consolidated statements of cash flows for the nine months ended March 31, 2012 and 2011 are unaudited but, in management’s opinion, include all adjustments, consisting only of normal recurring accruals, necessary for a fair presentation of the results of the interim periods. The accompanying condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended June 30, 2011, including items incorporated by reference therein.

Revenue Recognition and Allowance for Doubtful Accounts
We recognize revenue based on guidance provided in SEC Staff Accounting Bulletin (“SAB”) No. 104, “Revenue Recognition” and in accordance with authoritative guidance issued by the Financial Accounting Standard Board (“FASB”) pertaining to revenue arrangements with multiple deliverables. We recognize revenue when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, our price is fixed or determinable and collectability is reasonably assured. We recognize revenue on our standard products when title passes to the customer upon shipment. While our standard products generally require installation, the installation is considered a perfunctory performance obligation. Standard products do not have customer acceptance criteria. Generally, software is a component of our standard product and, as such, is not separately recognized as revenue. We have standard rights of return for defective products that we account for as a warranty provision under authoritative guidance of accounting for contingencies. We do not have any price protection agreements or other post shipment obligations. For custom equipment where customer acceptance is part of the sales agreement, revenue is recognized when the customer has accepted the product. In cases where custom equipment does not have customer acceptance as part of the sales agreement, we recognize revenue upon shipment as long as the system meets the specifications as agreed upon with the customer. Certain transactions have multiple deliverables, with the deliverables clearly defined. To the extent that the secondary deliverables are other than perfunctory, we recognize the revenue on each deliverable, if separable, or on the completion of all deliverables, if not separable, all in a manner consistent with SAB No. 104 and related authoritative guidance. Standalone software products are recognized as revenue when they are shipped.

Certain customer transactions include payment terms whereby we receive a partial payment of the total order amount prior to the related revenue being recognized in our financial statements. These advance payments are included in progress payments, deferred revenue and billings in excess of costs and estimated earnings in the condensed consolidated balance sheet. Generally, these progress payments relate to orders for custom equipment that require a lengthy build cycle and, in some cases, acceptance by the customer. We may negotiate payment terms with these customers on these particular orders and secure certain payments prior to or on shipment of the equipment. These payments remain in progress payments, deferred revenue and billings in excess of costs and estimated earnings until our applicable revenue recognition criteria have been met.

6


Certain contracts we enter into continue over an extended period of time. We review those contracts for possible revenue recognition as a long-term contract. If long-term contract accounting is appropriate, we then evaluate whether revenues should be recognized using the percentage-of-completion method. Under the percentage-of-completion method, we develop estimates as a basis for contract revenue and costs in progress as work on the contract continues. Estimates are reviewed and revised as additional information becomes available. Billings in excess of costs and earnings are included in progress payments, deferred revenue and billings in excess of costs and estimated earnings in the condensed consolidated balance sheets. The percentage-of-completion method is used in circumstances in which all the following conditions exist:

 

 

 

The contract includes enforceable rights regarding goods or services to be provided to the customer, the consideration to be exchanged, and the manner and terms of settlement.

Both the Company and the customer are expected to satisfy all contractual obligations; and,

Reasonably reliable estimates of total revenue, total cost and the progress toward completion can be made.

We maintain an allowance for doubtful accounts based on a continuous review of customer accounts, payment patterns and specific collection issues. We perform on-going credit evaluations of our customers and do not require collateral from our customers. For many of our international customers, we require an irrevocable letter of credit from the customer before a shipment is made. If the financial condition of one or more of our customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required.

Discontinued Operations
The Company classifies operations as discontinued when the operations have either ceased, or are expected to be disposed of in a sale transaction in the near term, the operations and cash flows of all discontinued operations have been eliminated or will be eliminated upon consummation of the expected sale transaction, and the Company will not have any significant continuing involvement in the discontinued operations. As more fully described in Note 2, “Discontinued Operations”, we have discontinued the Singapore IC packaging operations of our Vision Systems product line, which was included in our Metrology Solutions segment.

Recent Accounting Guidance Not Yet Adopted

In June 2011, the FASB issued new guidance on the presentation of comprehensive income that will require presentation of components of net income and other comprehensive income in one continuous statement or in two separate, but consecutive statements. There are no changes to the components that are recognized in net earnings or other comprehensive income under current US GAAP. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2011, with early adoption permitted. It is applicable to our fiscal periods beginning and subsequent to July 1, 2012. We are currently evaluating this guidance, but do not expect its adoption to have a material effect on our consolidated financial statements.

Adoption of New Accounting Pronouncements

In May 2011, the FASB issued guidance to amend certain measurement and disclosure requirements related to fair value measurements to improve consistency with international reporting standards. This guidance is effective prospectively for public entities for interim and annual reporting periods beginning after December 15, 2011, with early adoption by public entities prohibited, and is applicable to our fiscal periods beginning and subsequent to January 1, 2012. The adoption of this guidance did not have a material impact on our condensed consolidated financial statements.

In January 2010, the FASB issued amended standards that require additional fair value disclosures. These disclosure requirements are effective in two phases. On January 1, 2010, we adopted the requirements for disclosures about inputs and valuation techniques used to measure fair value as well as disclosures about significant transfers. The adoption of this portion of the guidance did not have a material impact on our condensed consolidated financial statements. On July 1, 2011, we adopted the requirements for disclosures concerning the presentation of disaggregated activity within the reconciliation for fair value measurements using significant unobservable inputs (Level 3). The adoption of the balance of these amended standards did not have a material impact on our condensed consolidated financial statements.

In December 2010, the FASB also issued guidance to clarify the reporting of pro forma financial information related to business combinations of public entities and to expand certain supplemental pro forma disclosures. This guidance is effective prospectively for business combinations that occur on or after the beginning of a fiscal year beginning on or after December 15, 2010, with early adoption permitted. It was applicable to our fiscal year beginning July 1, 2011. The adoption of this guidance did not have a material impact on our condensed consolidated financial statements.

7


Note 2: Discontinued Operations

We discontinued the Singapore IC packaging operations of our Vision Systems product line in fiscal 2010. In accordance with authoritative guidance, the results of operations for the aforementioned operations are presented in the Company’s condensed consolidated financial statements as discontinued operations. In addition, adjustments were made to the carrying value of assets held for sale if the carrying value exceeded their estimated fair value less cost to sell. We recognized $91 of income from discontinued operations in the nine months ended March 31, 2011.

The following table sets forth the assets and liabilities of our discontinued operations included in the condensed consolidated balance sheets of the Company as of March 31, 2012 and June 30, 2011:

 

 

 

 

 

 

 

 

 

 

March 31,
2012

 

June 30,
2011

 

 

 


 


 

Accrued expenses and other current liabilities

 

$

 

$

281

 

 

 



 



 

Current liabilities of discontinued operations

 

$

 

$

281

 

 

 



 



 

Note 3: Acquisitions

Richmond, California

On November 12, 2010, we completed a transaction with ASML US, Inc. (“ASML”) to purchase substantially all the assets of their Richmond, California operations (“Richmond asset acquisition”), including a 55,300 square-foot manufacturing facility. This acquisition expanded our optical manufacturing capabilities. The assets were acquired for $12,475, of which $7,142 was in cash, and the balance was future consideration, with a net present value of $5,333 using a discount factor of 14%, based on the level of shipments to ASML over the subsequent three years beginning January 1, 2011. On the acquisition date, the future consideration was recorded as a liability, with $1,127 recorded as a current liability and $4,206 recorded as a long-term liability. The future consideration represented a supply agreement that was entered into with ASML that provided for a volume discount. In addition, we hired key management and employees working at the Richmond facility. These activities resulted in a newly formed operation known as the Extreme Precision Optics group (“EPO”) which is included in our Optical Systems segment. On June 30, 2011, we recorded a final valuation adjustment that increased both property, plant and equipment and gain on acquisition by $7.

This transaction met the conditions of a business combination as defined by Accounting Standards Codification (“ASC”) 805 and, as such, is accounted for under ASC 805 using the purchase method of accounting. ASC 805 defines the three elements of a business as Input, Process and Output. As a result of the acquisition of substantially all the Richmond facility assets, Zygo acquired the machinery and equipment utilized in the processes to manufacture product, the building that houses the entire operation and intellectual property needed in the process to manufacture the product. The ASML employees hired by Zygo in connection with the acquisition brought with them the skills, experience and know-how necessary to provide the operational processes that, when applied to the acquired assets, represent processes being applied to inputs to create outputs. Having met all three elements of a business as defined in ASC 805, we determined that the Richmond asset acquisition should be accounted for as a business acquisition.

The results of EPO are included in our consolidated statements of operations from the acquisition date. Zygo performed a preliminary fair value exercise to allocate the purchase price to the acquired assets and liabilities at November 12, 2010. The fair value exercise was completed at June 30, 2011. The following table summarizes the consideration paid for the business and the final fair values of the assets acquired at the date of acquisition:

 

 

 

 

 

 

 

 

 

Final Fair Value as of June 30, 2011

 

 

 


 

Consideration:

 

 

 

 

 

 

Cash

 

$

7,142

 

Future consideration

 

 

 

5,333

 

 

 

 



 

Purchase Price

 

$

12,475

 

 

 



 

Assets Acquired:

 

 

 

 

 

 

Inventories

 

$

2,399

 

Property, plant and equipment

 

 

 

11,474

 

 

Technology and customer relationships

 

 

623

 

 

 



 

Total assets

 

 

 

14,496

 

 

 

 

 

 

 

Less gain on acquisition

 

 

2,021

 

 

 



 

Purchase Price

 

 

$

12,475

 

 

 

 



 

8


In addition to recording the fair values of the assets acquired and the future consideration liability, we also recorded a gain on acquisition of $2,014 in the three months ended December 31, 2010 and an additional $7 in the three months ended June 30, 2011 in the consolidated statement of operations within gain on acquisition in accordance with ASC 805 using the purchase method of accounting. The gain on acquisition was primarily due to the difference between market value of the acquired real estate and its book value and the desire of ASML to sell the assets. In addition, a deferred tax liability of $725 was recorded in the opening balance sheet, which had the effect of reducing the gain on acquisition to $1,296 by June 30, 2011. We maintain a full valuation allowance on our net deferred tax assets. Therefore, we recorded a tax benefit to reduce the valuation allowance to the net deferred tax asset balance. Prior to recording the gain, we reassessed whether we had correctly identified all of the assets acquired and all of the liabilities assumed. Additionally, we also reviewed the procedures used to measure the amounts of the identifiable assets acquired, liabilities assumed and consideration transferred.

The purchased inventory was comprised of raw materials and work in process. The fair value for work in process was $1,833 and was determined by considering the sales price of finished units to represent fair value. The fair value for the building and land was $6,080 and was determined by using the sales comparison approach to value the land and a combination of the sales and cost approach for the building and improvements. The fair value of the equipment was determined by the market approach to be $5,394. Fair value of customer relationships was determined to be $23 by using the multi-period excess earnings method. The fair value of technology was $600 and was determined using the relief from royalty method.

During the three months ended March 31, 2011, the EPO operations contributed revenue and net earnings of $6,279 and $2,096, respectively. During the nine months ended March 31, 2011, the EPO operations contributed revenue and net earnings of $8,775 and $2,617, respectively. Acquisition related expenses of $406 was recognized in administration expense for the nine months ended March 31, 2011, respectively.

Proforma financial information of revenues and net earnings for the operation is impractical to provide. Prior to the acquisition, the Richmond operations were accounted for as a cost center within ASML. Therefore, revenues were not recorded at the Richmond level within ASML and separate financial statements for the Richmond operations were not prepared. While ASML provided financial information sufficient for Zygo to conclude that the acquisition was not significant under Regulation S-X rule 3-05, ASML did not provide and Zygo does not have access to financial information for the appropriate periods to present pro forma financial information.

The following disclosure presents certain information regarding the Company’s acquired intangible assets as of March 31, 2011. All acquired intangible assets were valued by the income approach and are being amortized over their initial estimated useful lives of five years for both customer relationships and technology, in both instances with no estimated residual values. We test our intangible assets for impairment annually.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Customer
Relationships

 

Technology

 

Total

 

 

 

 


 


 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at November 12, 2010

 

$

23

 

$

600

 

$

623

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amortization expense

 

 

(2

)

 

(45

)

 

(47

)

 

 

 



 



 



 

 

Balance at March 31, 2011

 

$

21

 

$

555

 

$

576

 

 

 

 



 



 



 

9


Note 4: Restructuring and Related Costs

During fiscal 2009, we initiated restructuring actions related to ongoing cost reduction efforts comprised of workforce reductions and the consolidation of manufacturing operations in Tucson, Arizona.

The following table summarizes the accrual balances and utilization by cost type and restructuring payment activity for the nine months ended March 31, 2012 and 2011:

 

 

 

 

 

 

 

 

 

 

 

 

 

Severance

 

Facility
Consolidation
Costs

 

Total

 

 

 


 


 


 

Balance at June 30, 2011

 

$

 

$

33

 

$

33

 

Payments

 

 

 

 

(33

)

 

(33

)

 

 



 



 



 

Balance at March 31, 2012

 

$

 

$

 

$

 

 

 



 



 



 


 

 

 

 

 

 

 

 

 

 

 

 

 

Severance

 

Facility
Consolidation
Costs

 

Total

 

 

 


 


 


 

Balance at June 30, 2010

 

$

290

 

$

227

 

$

517

 

Payments

 

 

(241

)

 

(145

)

 

(386

)

 

 



 



 



 

Balance at March 31, 2011

 

$

49

 

$

82

 

$

131

 

 

 



 



 



 

There were no restructuring charges in the nine months ended March 31, 2012 and the twelve months ended June 30, 2011. The cumulative amount of restructuring charges incurred through March 31, 2012 was $2,819, of which $2,158 was related to severance and $661 related to facility consolidation costs.

Note 5: Earnings Per Share

For the three and nine months ended March 31, 2012, outstanding stock options and restricted stock awards for 32,378 and 270,143 shares (for the three and nine months ended March 31, 2011, 399,214 and 963,623 shares) of the Company’s common stock were excluded from the calculation of diluted earnings per share because they were antidilutive.

The following table sets forth the reconciliation of basic weighted average shares outstanding and diluted weighted average shares outstanding for the periods presented:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31,

 

Nine Months Ended March 31,

 

 

 


 


 

 

 

2012

 

2011

 

2012

 

2011

 

 

 


 


 


 


 

Basic weighted average shares outstanding

 

 

18,116,470

 

 

17,692,761

 

 

17,947,928

 

 

17,599,732

 

Dilutive effect of stock options and restricted shares

 

 

766,681

 

 

611,693

 

 

692,166

 

 

456,239

 

 

 



 



 



 



 

Diluted weighted average shares outstanding

 

 

18,883,151

 

 

18,304,454

 

 

18,640,094

 

 

18,055,971

 

 

 



 



 



 



 

10


Note 6: Comprehensive Income

The following table sets forth comprehensive income within stockholders’ equity and noncontrolling interests for the nine months ended March 31, 2012 and 2011:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended March 31,

 

 

 


 

 

 

2012

 

2011

 

 

 


 


 

 

 

Stockholders’
Equity
Zygo Corp.

 

Non-
Controlling
Interests

 

Total
Equity

 

Stockholders’
Equity
Zygo Corp.

 

Non-
Controlling
Interests

 

Total
Equity

 

 

 


 


 


 


 


 


 

Equity, beginning of period

 

$

124,720

 

$

3,367

 

$

128,087

 

$

98,403

 

$

2,193

 

$

100,596

 

Comprehensive income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net earnings

 

 

18,054

 

 

1,605

 

 

19,659

 

 

12,975

 

 

1,205

 

 

14,180

 

Foreign currency translation effect

 

 

(848

)

 

(159

)

 

(1,007

)

 

1,637

 

 

320

 

 

1,957

 

 

 



 



 



 



 



 



 

Total other comprehensive income

 

 

17,206

 

 

1,446

 

 

18,652

 

 

14,612

 

 

1,525

 

 

16,137

 

 

 



 



 



 



 



 



 

Share based compensation

 

 

3,332

 

 

 

 

3,332

 

 

2,962

 

 

 

 

2,962

 

Repurchase of restricted stock

 

 

(401

)

 

 

 

(401

)

 

(285

)

 

 

 

(285

)

Exercise of employee stock options and related tax effect

 

 

2,882

 

 

 

 

2,882

 

 

1,498

 

 

 

 

1,498

 

Dividends attributable to noncontrolling interests

 

 

 

 

(2,192

)

 

(2,192

)

 

 

 

(823

)

 

(823

)

 

 



 



 



 



 



 



 

Equity, end of period

 

$

147,739

 

$

2,621

 

$

150,360

 

$

117,190

 

$

2,895

 

$

120,085

 

 

 



 



 



 



 



 



 

11


Note 7: Marketable Securities
Marketable securities consisted of a mutual fund investment consisting primarily of corporate securities as of March 31, 2012 which is classified as a trading security. Marketable securities consisted of a government agency security, classified as held-to-maturity, and mutual funds consisting primarily of corporate securities as of June 30, 2011. Dividend and interest income is recognized when earned. Straight-line amortization related to discounts and premiums on the purchase of marketable securities is recorded in interest income. Realized gains and losses are included in earnings and are derived using the specific identification method for determining the cost of securities sold.

There were no held-to-maturity securities at March 31, 2012. At June 30, 2011, the held-to-maturity securities consisted of a government treasury bill. The amortized cost, gross unrealized gains and losses and fair value of held-to-maturity securities at June 30, 2011 were as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amortized
Cost

 

Gross
Unrealized
Gains

 

Gross
Unrealized
Losses

 

Fair
Value

 

 

 

 


 


 


 


 

 

At June 30, 2011
Government treasury bill

 

$

1,000

 

$

 

$

 

$

1,000

 

 

 

 



 



 



 



 


Trading securities consisted of a mutual fund investment corresponding to elections made in our deferred compensation program. In December 2010, we began quarterly distributions in accordance with the deferred compensation program agreement. The following table sets forth the beginning balance at July 1, 2011 and 2010, gross unrealized gains and losses, contributions, redemptions and fair value of trading securities at March 31, 2012 and 2011:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Beginning
Balance of
Fiscal Year

 

Gross
Unrealized
Gains

 

Gross
Unrealized
Losses

 

Contri-
butions

 

Redemp-
tions

 

Ending
Balance

 

 

 


 


 


 


 


 


 

March 31, 2012

 

 

 

 

 

 

 

 

 

 

 

Mutual Fund

 

$

980

 

$

99

 

$

(134

)

$

 

$

(127

)

$

818

 

 

 



 



 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31, 2011

 

 

 

 

 

 

 

 

 

 

 

Mutual Fund

 

$

922

 

$

194

 

$

 

$

 

$

(89

)

$

1,027

 

 

 



 



 



 



 



 



 

There were no securities in a continuous unrealized loss position at June 30, 2011. In determining whether investment holdings are other than temporarily impaired, we consider the nature, cause, severity and duration of the impairment. We and our investment advisors use analyst reports, credit ratings and other items as part of our review.

12


Note 8. Fair Value Measurements

Fair value measurement disclosures utilize a valuation hierarchy for determining the grouping of the inputs used. This hierarchy prioritizes the inputs into three broad levels. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument. Level 3 inputs are unobservable inputs based on management’s assumptions used to measure assets and liabilities at fair value. The classification of financial assets and liabilities within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.

When available, the Company uses quoted market prices to determine the fair value of its assets and liabilities included in Level 1. When quoted market prices are unobservable, the Company uses quotes from independent pricing vendors based on recent trading activity and other relevant information. The carrying value of other financial instruments, including cash, accounts receivable, accounts payable and accrued liabilities, approximates fair value due to their short maturities.

The following tables provide the assets and liabilities carried at fair value measured on a recurring basis as of March 31, 2012 and June 30, 2011:

Assets Measured at Fair Value:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair value measurements at March 31, 2012

 

 

 

 

 

 


 

 

 

Total carrying
value at
March 31,
2012

 

Quoted prices
in active
markets
(Level 1)

 

Significant
other
observable
inputs
(Level 2)

 

Significant
unobservable
inputs
(Level 3)

 

 

 


 


 


 


 

Money market funds

 

$

19,930

 

$

19,930

 

$

 

$

 

Trading securities

 

 

818

 

 

818

 

 

 

 

 

Foreign currency hedge

 

 

78

 

 

78

 

 

 

 

 

 

 



 



 



 



 

Total

 

$

20,826

 

$

20,826

 

$

 

$

 

 

 



 



 



 



 

Assets and Liabilities Measured at Fair Value:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair value measurements at June 30, 2011

 

 

 

 

 

 


 

 

 

Total carrying
value at
June 30, 2011

 

Quoted prices
in active
markets
(Level 1)

 

Significant
other
observable
inputs
(Level 2)

 

Significant
unobservable
inputs
(Level 3)

 

 

 


 


 


 


 

Money market funds

 

$

19,930

 

$

19,930

 

$

 

$

 

Trading securities

 

 

980

 

 

980

 

 

 

 

 

Foreign currency hedge

 

 

(82

)

 

 

 

(82

)

 

 

 

 



 



 



 



 

Total

 

$

20,828

 

$

20,910

 

$

(82

)

$

 

 

 



 



 



 



 

13


Note 9: Share-Based Payments

We recorded share-based compensation expense for the three months ended March 31, 2012 and 2011 of $1,014 and $1,081, respectively, with a related tax benefit of $365 and $389, respectively. We also recorded share-based compensation expense for the nine months ended March 31, 2012 and 2011 of $3,332 and $2,962, respectively, with a related tax benefit of $1,200 and $1,067, respectively.

Stock Options
We use the Black-Scholes option-pricing model to calculate the fair value of stock option awards. The key assumptions for this valuation method include the expected term of the option, stock price volatility, risk-free interest rate, dividend yield and exercise price. Many of these assumptions are judgmental and highly sensitive in the determination of compensation expense. Under the assumptions indicated below, the weighted-average fair value of stock option grants for the three months ended March 31, 2012 and 2011 was $10.50 and $8.37, respectively. Under the assumptions indicated below, the weighted-average fair value of stock option grants for the nine months ended March 31, 2012 and 2011 was $7.21 and $5.68, respectively. During the three months ended March 31, 2012 and 2011, we issued stock options for an aggregate of 6,500 and 50,000 shares of common stock, respectively. During the nine months ended March 31, 2012 and 2011, we issued stock options for an aggregate of 229,562 and 100,000 shares of common stock, respectively.

The table below indicates the key assumptions used in the option valuation calculations for options granted in the periods presented:

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31,

 

Nine Months Ended March 31,

 

 

 


 


 

 

 

2012

 

2011

 

2012

 

2011

 

 

 


 


 


 


 

Term

 

6.6 Years

 

5.1 Years

 

6.6 Years

 

4.1-5.1 Years

 

Volatility

 

59.5%

 

57.1%

 

59.5%

 

45.7%-57.1%

 

Dividend yield

 

0.0%

 

0.0%

 

0.0%

 

0.0%

 

Risk-free interest rate

 

1.5%

 

2.6%

 

1.5%

 

1.1-2.6%

 

Restricted Stock
Our share-based compensation expense also includes the effects of the issuance of restricted stock units. The compensation expense related to restricted stock awards is determined based on the market price of our stock at the date of grant applied to the total number of shares that are anticipated to fully vest, which is then amortized over the expected term. During the three months ended March 31, 2011, an aggregate of 73,500 shares of restricted stock units were issued at a weighted average stock price at date of grant of $12.01. There were no shares of restricted stock issued during the three months ended March 31, 2012. During the nine months ended March 31, 2012 and 2011, an aggregate of 146,412 and 362,500 shares, respectively, of restricted stock units were issued at a weighted average stock price at date of grant of $13.24 and $10.75, respectively. Generally, the restrictions on the restricted stock units granted to employees prior to January 1, 2011 lapse at a rate of 50% after three years and the remaining 50% after the fourth year. Restrictions on restricted stock units granted to employees after January 1, 2011 lapse at a rate of 25% each year.

Note 10: Receivables

The following table sets forth the components of accounts receivable at March 31, 2012 and June 30, 2011:

 

 

 

 

 

 

 

 

 

 

March 31, 2012

 

June 30,
2011

 

 

 


 


 

Trade

 

$

24,034

 

$

32,515

 

Other

 

 

330

 

 

308

 

 

 



 



 

 

 

 

24,364

 

 

32,823

 

Allowance for doubtful accounts

 

 

(908

)

 

(1,399

)

 

 



 



 

 

 

$

23,456

 

$

31,424

 

 

 



 



 

14


Note 11: Inventories

Inventories are stated at the lower of cost (determined on a first-in, first-out basis) or market. The following table sets forth the components of inventories at March 31, 2012 and June 30, 2011:

 

 

 

 

 

 

 

 

 

 

 

 

March 31,
2012

 

June 30,
2011

 

   

 

 


 


 

   

Raw materials and manufactured parts

 

$

12,483

 

$

13,265

 

   

Work in process

 

 

12,356

 

 

10,742

 

   

Finished goods

 

 

2,809

 

 

4,372

 

   

 

 



 



 

   

 

 

$

27,648

 

$

28,379

 

   

 

 



 



 

   

Note 12: Property, Plant and Equipment

Property, plant and equipment are stated at cost less impairments. Maintenance and repairs are charged to expense as incurred. Management evaluates, on an ongoing basis, the carrying value of property, plant and equipment and makes adjustments when impairments are identified. Depreciation is based on the estimated useful lives of the various classes of assets and is computed using the straight-line method. The following table sets forth the components of property, plant and equipment at March 31, 2012 and June 30, 2011:

 

 

 

 

 

 

 

 

 

 

 

 

March 31,
2012

 

June 30,
2011

 

Estimated Useful Life
(Years)

 

 

 


 


 


Land and improvements

 

$

2,930

 

$

2,930

 

 

Building and improvements

 

 

21,295

 

 

21,265

 

15-40

 

Machinery, equipment and office furniture

 

 

59,361

 

 

58,157

 

3-8

 

Leasehold improvements

 

 

984

 

 

989

 

1-5

 

Construction in progress

 

 

153

 

 

357

 

 

 

 



 



 

 

 

 

 

 

84,723

 

 

83,698

 

 

 

Accumulated depreciation

 

 

(55,805

)

 

(53,503

)

 

 

 

 



 



 

 

 

 

 

$

28,918

 

$

30,195

 

 

 

 

 



 



 

 

 

Depreciation expense was $1,168 and $1,342 for the three months ended March 31, 2012 and 2011, respectively, and $3,670 and $3,951 for the nine months ended March 31, 2012 and 2011, respectively.

15


Note 13: Warranty

A limited warranty is provided on our products for periods ranging from 3 to 24 months, and allowances for estimated warranty costs are recorded during the period of sale. The determination of such allowances requires management to make estimates of product return rates and expected costs to repair or replace products under warranty. If actual return rates or repair and replacement costs, or both, differ significantly from management’s estimates, adjustments to the expense will be required.

The following table sets forth a reconciliation of the accrued warranty liability:

 

 

 

 

 

 

 

 

 

 

Nine Months Ended March 31,

 

 

 


 

 

 

2012

 

2011

 

 

 


 


 

Beginning balance

 

$

1,333

 

$

1,360

 

Reductions for payments made

 

 

(938

)

 

(788

)

Changes in accruals related to pre-existing warranties

 

 

202

 

 

362

 

Changes in accruals related to warranties made in the current period

 

 

661

 

 

350

 

 

 



 



 

Ending balance

 

$

1,258

 

$

1,284

 

 

 



 



 

Note 14: Intangible Assets

Intangible assets includes patents and trademarks, customer relationships and technology and a covenant not-to-compete. The cost of patents and trademarks, and customer relationships and technology is amortized on a straight-line basis over estimated useful lives ranging from 3-17 years. We entered into a non-compete agreement with a former officer and director of the Company effective February 28, 2009. The agreement calls for payments over a four year period of declining amounts totaling $878, which includes $27 of imputed interest. As of March 31, 2012, current liabilities includes $51 related to the payments under this agreement. We are amortizing the value of the non-compete over four years on a declining balance method.

The following table sets forth the components of intangible assets, as of March 31, 2012 and June 30, 2011:

 

 

 

 

 

 

 

 

 

 

March 31,
2012

 

June 30,
2011

 

 

 


 


 

Patents and trademarks

 

$

6,920

 

$

6,774

 

Customer relationships and technology

 

 

2,163

 

 

2,163

 

Covenant not-to-compete

 

 

851

 

 

851

 

 

 



 



 

 

 

 

9,934

 

 

9,788

 

Accumulated amortization

 

 

(4,541

)

 

(3,946

)

 

 



 



 

Total

 

$

5,393

 

$

5,842

 

 

 



 



 

Amortization expense related to intangibles was $203 and $275 for the three months ended March 31, 2012 and 2011, respectively and was $623 and $768 for the nine months ended March 31, 2012 and 2011, respectively. This amortization expense related to intangible assets is included in cost of goods sold and selling, general and administrative expenses in the condensed consolidated statements of operations.

Based on the carrying amount of the intangible assets as of March 31, 2012, the estimated future amortization expense is as follows:

 

 

 

 

 

 

 

 

 

Estimated Future Amortization
Expense

 

 

 


 

Three months ending June 30, 2012

 

 

$

274

 

 

Fiscal year ending June 30, 2013

 

 

894

 

Fiscal year ending June 30, 2014

 

 

 

800

 

 

Fiscal year ending June 30, 2015

 

 

788

 

Fiscal year ending June 30, 2016

 

 

 

612

 

 

Fiscal year ending June 30, 2017

 

 

473

 

Thereafter

 

 

 

1,552

 

 

 

 



 

Total

 

$

5,393

 

 

 



 

16


Note 15: Segment and Major Customer Information

Our business is organized into two operating divisions – Metrology Solutions (Metrology Solutions segment) and Optical Systems (Optical Systems segment). Consistent with our business structure, we reported our segments as Metrology and Optics. Our Metrology Solutions segment includes 3-Dimensional surface metrology products, precision positioning systems and custom-engineered solutions used in the semiconductor, research, defense and industrial markets. Our Optical Systems segment designs, develops and manufactures high precision optical components and electro-optical systems used in the semiconductor, defense, life sciences and research markets. The chief operating decision-maker uses this information to allocate resources.

The following table sets forth segment net revenues, gross profit and gross margin for the three and nine months ended March 31, 2012 and 2011:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31,

 

Nine Months Ended March 31,

 

 

 


 


 

 

 

2012

 

2011

 

2012

 

2011

 

 

 


 


 


 


 

Metrology Solutions

 

 

 

 

 

 

 

 

 

 

 

 

 

Net revenues

 

$

24,161

 

$

22,506

 

$

79,482

 

$

66,923

 

Gross profit

 

$

14,033

 

$

12,338

 

$

46,474

 

$

37,129

 

Gross margin

 

 

58

%

 

55

%

 

58

%

 

55

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Optical Systems

 

 

 

 

 

 

 

 

 

 

 

 

 

Net revenues

 

$

14,311

 

$

17,729

 

$

43,022

 

$

40,517

 

Gross profit

 

$

5,407

 

$

6,526

 

$

14,225

 

$

12,832

 

Gross margin

 

 

38

%

 

37

%

 

33

%

 

32

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

Net revenues

 

$

38,472

 

$

40,235

 

$

122,504

 

$

107,440

 

Gross profit

 

$

19,440

 

$

18,864

 

$

60,699

 

$

49,961

 

Gross margin

 

 

51

%

 

47

%

 

50

%

 

47

%

Separate financial information by segment for total assets, capital expenditures and depreciation and amortization is not evaluated by our chief operating decision-maker. Substantially all of our operating expenses, assets and depreciation and amortization are U.S. based.

The following table sets forth revenues by geographic area:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31,

 

Nine Months Ended March 31,

 

 

 


 


 

 

 

2012

 

2011

 

2012

 

2011

 

 

 


 


 


 


 

Americas

 

$

18,270

 

$

21,497

 

$

64,730

 

$

57,977

 

Japan

 

 

7,228

 

 

9,472

 

 

19,707

 

 

23,265

 

China

 

 

5,288

 

 

1,840

 

 

15,191

 

 

5,919

 

Europe

 

 

5,093

 

 

4,973

 

 

15,199

 

 

13,349

 

Pacific Rim

 

 

2,593

 

 

2,453

 

 

7,677

 

 

6,930

 

 

 



 



 



 



 

Total

 

$

38,472

 

$

40,235

 

$

122,504

 

$

107,440

 

 

 



 



 



 



 

Revenues from two customers accounted for 13% and 10% of the net revenues for the three months ended March 31, 2012 (revenues from two customers accounted for 11% each of the net revenues for the nine months ended March 31, 2012). Revenues from two customers accounted for 16% and 11% of the net revenues for the three months ended March 31, 2011 (revenues from one customer accounted for 12% of net revenues for the nine months ended March 31, 2011). Revenues from these customers were included in both of our segments.

17


Note 16: Transactions with Stockholder

Revenues from Canon Inc., a stockholder, and Canon Sales Co., Inc., a distributor of certain of our products in Japan and a subsidiary of Canon Inc. (collectively referred to as “Canon”), amounted to $4,970 and $6,434 (13% and 16% of net revenues, respectively) for the three months ended March 31, 2012 and 2011, respectively. For the nine months ended March 31, 2012 and 2011, sales to Canon amounted to $14,023 and $13,387 (11% and 12% of net revenues, respectively.) Selling prices of products sold to Canon are based, generally, on the terms customarily given to distributors. At March 31, 2012 and June 30, 2011, there were, in the aggregate, $1,287 and $2,572, respectively, of trade accounts receivable from Canon.

Note 17: Derivatives and Hedging Activities

We enter into foreign currency forward contracts to reduce the impact of adverse fluctuations on earnings associated with foreign currency exchange rate changes. We do not enter into any derivative transactions for speculative purposes. The contracts are not designated as cash flow, fair value, or net investment hedges as defined under authoritative guidance on accounting for derivative instruments and hedging activities. These contracts are marked-to-market with changes in fair value recorded in the condensed consolidated statements of operations in miscellaneous income. The contracts are entered into for periods consistent with the expected currency transaction exposures, generally three to six months. Any gains and losses on the fair value of these contracts are expected to substantially offset corresponding losses and gains on the underlying transactions.

As of March 31, 2012, there were five currency contracts outstanding involving our Japanese and German operations with notional amounts aggregating $1,990. These foreign currency hedges are not designated as hedging instruments. For the three months ended March 31, 2012 and 2011, we recognized net unrealized gains of $90 and $56, respectively, from foreign currency forward contracts. For the nine months ended March 31, 2012 and 2011, we recognized net unrealized gains of $160 and $30, respectively, from foreign currency forward contracts. These unrealized gains are essentially offset by foreign exchange losses on intercompany balances recorded by our subsidiaries and are recorded in miscellaneous income on our condensed consolidated statements of operations.

The following table summarizes the fair value of derivative instruments as of March 31, 2012 and 2011:

 

 

 

 

 

 

 

 

 

 

Derivatives not designated as hedging instruments

 

Balance Sheet Location


 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31, 2012

 

Number of foreign exchange contracts:

 

5

 

Prepaid expenses and other

 

$78

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31, 2011

 

Number of foreign exchange contracts:

 

10

 

Other accrued liabilities

 

$40

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

18


Note 18: Income Taxes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31,

 

Nine Months Ended March 31,

 

 

 


 


 

 

 

2012

 

2011

 

2012

 

2011

 

 

 


 


 


 


 

 

 

Amount

 

Tax
Rate %

 

Amount

 

Tax
Rate %

 

Amount

 

Tax
Rate %

 

Amount

 

Tax
Rate %

 

 

 


 


 


 


 


 


 


 


 

 

Income tax expense

 

$

772

 

 

12

%

$

720

 

 

13

%

$

2,381

 

 

11

%

$

1,474

 

 

9

%

Income tax expense for the three and nine months ended March 31, 2012 and 2011 related primarily to foreign and state income tax expense. There was no current United States (“U.S.”) federal income tax expense due to our net operating loss (“NOL”) carryforwards and the valuation allowance on those NOL’s. During fiscal 2011, we also recognized $725 of tax benefit from an adjustment of valuation allowances on our deferred tax assets associated with the Richmond asset acquisition. The Company is subject to U.S. federal income tax as well as income tax in multiple state and foreign jurisdictions. The Company is no longer subject to U.S. federal income tax audit or tax adjustments for years prior to June 30, 2007, except to the extent there are NOLs and credits arising from any of those years. Those years are subject to audit at the time the NOL or credit is utilized. The Company is no longer subject to state and foreign income tax audit or tax adjustments for years prior to June 30, 2006.

We utilize the asset and liability method of accounting for income taxes. The Company records deferred tax assets to the extent we believe these assets will more likely than not be realized. In making such determination, we consider all available positive and negative evidence, including recent financial performance over the last three fiscal years, scheduled reversals of deferred tax liabilities, projected future taxable income and tax planning strategies. Based upon the Company’s review of all positive and negative evidence, we concluded that a full valuation allowance should continue to be recorded against our U.S. net deferred tax assets at March 31, 2012. In the future, if we determine that it is more likely than not that we will realize our U.S. net deferred tax assets, we will reverse the applicable portion of the valuation allowance and recognize an income tax benefit in the period during which such determination is made.

In the normal course of business, we provide for uncertain tax positions and adjust our unrecognized tax benefits or liabilities accordingly. For the nine months ended March 31, 2012, we recognized additional liability of $523 for changes in our tax positions. We are not aware of any tax positions that would create a material adjustment to the unrecognized tax benefits during the next twelve months.

Note 19: Commitments and Contingencies

From time to time we are subject to certain legal proceedings and claims that arise in the normal course of our business.

We are aware of certain levels of environmental contamination that are below reportable levels on one of our properties. In addition, we are aware of certain contamination on an adjacent property that we formerly owned. The future effect of environmental matters, including potential liabilities, is often difficult to estimate. At this time, we are unable to determine or reasonably estimate the amount of costs, if any, that we might incur or for which we may potentially be responsible. We will record a reserve for the exposure related to the environmental contamination when and if it is both probable that a liability has been incurred and the amount of any liability can be reasonably estimated, whether or not a claim has been asserted.

19


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

OVERVIEW

Zygo Corporation is a worldwide supplier of optical metrology instruments, precision optics and electro-optical design and manufacturing services, serving customers in the semiconductor capital equipment, research, defense, life sciences and industrial markets. We conduct the majority of our manufacturing in our 153,500 square foot facility in Middlefield, Connecticut, our 55,300 square foot facility in Richmond, California, and our 22,560 square foot facility in Tucson, Arizona.

Bookings for the third quarter of fiscal 2012 were $45.6 million, an increase of 9% compared with bookings of $41.7 million in the third quarter of fiscal 2011. Bookings for the Metrology Solutions Division were 44% of the total; Optical Systems Division bookings were 56%. Optical Systems Division bookings included two large bookings totaling over $13.0 million from the semiconductor and medical device markets. Revenues related to these bookings are expected to be recognized over the next four quarters.

Backlog increased to $76.8 million at March 31, 2012, compared with $60.5 million at March 31, 2011, and $69.7 million at December 31, 2011. During the previous four years, our backlog has been relatively evenly distributed between Metrology Solutions and Optical Systems. Currently, the backlog is represented 63% by Optical System bookings which generally carry a lower gross margin than Metrology Solutions. If the mix of revenues changes to a greater proportion of Optics revenues, it could affect reported gross margin. The impact on gross margin will also depend on future bookings, particularly Metrology bookings with shorter shipping cycles, and scheduled shipments on the existing backlog.

Net earnings of $5.4 million, or $0.29 per diluted share, for the third quarter of fiscal 2012 increased by 20% and 21% over net earnings of $4.5 million, or $0.24 per diluted share, recorded in the third quarter of fiscal 2011. Increased gross margins of 50.5% for the three months ended March 31, 2012, on a slightly lower revenue base ($1.8 million less), contributed to the higher net earnings over the comparable prior year period.

Net earnings of $18.1 million, or $0.97 per diluted share, for the first nine months of fiscal 2012 increased by 39% and 35%, or $5.1 million and $0.25 per diluted share, compared with the prior year period’s net earnings of $13.0 million, or $0.72 per diluted share. Net earnings for the nine months ended March 31, 2011 included a gain on acquisition of $2.0 million, net of tax, or $0.11 per diluted share, related to the acquisition of substantially all the assets of ASML US, Inc.’s Richmond, California operations (“Richmond asset acquisition”). This increase in net earnings for the nine months ended March 31, 2012 over the comparable prior year period is due to increased revenues and gross margins.

20


CRITICAL ACCOUNTING POLICIES, SIGNIFICANT JUDGMENTS AND ESTIMATES

The discussion and analysis of our financial condition and results of operations are based upon our condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these condensed consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, and expenses, and related disclosures at the date of our condensed consolidated financial statements. On an ongoing basis, management evaluates its estimates and judgments, including those related to bad debts, inventories, marketable securities, warranty obligations, income taxes, long-lived assets, share-based payments and accruals for health insurance. Management bases its estimates and judgments on historical experience and current market conditions and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. As discussed in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2011, management considers the Company’s policies on revenue recognition and allowance for doubtful accounts; inventory valuation; other than temporary impairment of marketable securities; share-based compensation; warranty costs; accounting for income taxes; valuation of long-lived assets; and accruals for health insurance to be critical accounting policies due to the estimates, assumptions and application of judgment involved in each.

Revenue Recognition and Allowance for Doubtful Accounts
We recognize revenue based on guidance provided in SEC Staff Accounting Bulletin (“SAB”) No. 104, “Revenue Recognition” and in accordance with authoritative guidance issued by the Financial Accounting Standard Board (“FASB”) pertaining to revenue arrangements with multiple deliverables. We recognize revenue when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, our price is fixed or determinable and collectability is reasonably assured. We recognize revenue on our standard products when title passes to the customer upon shipment. While our standard products generally require installation, the installation is considered a perfunctory performance obligation. Standard products do not have customer acceptance criteria. Generally, software is a component of our standard product and, as such, is not separately recognized as revenue. We have standard rights of return for defective products that we account for as a warranty provision under authoritative guidance of accounting for contingencies. We do not have any price protection agreements or other post shipment obligations. For custom equipment where customer acceptance is part of the sales agreement, revenue is recognized when the customer has accepted the product. In cases where custom equipment does not have customer acceptance as part of the sales agreement, we recognize revenue upon shipment as long as the system meets the specifications as agreed upon with the customer. Certain transactions have multiple deliverables, with the deliverables clearly defined. To the extent that the secondary deliverables are other than perfunctory, we recognize the revenue on each deliverable, if separable, or on the completion of all deliverables, if not separable, all in a manner consistent with SAB No. 104 and related authoritative guidance. Standalone software products are recognized as revenue when they are shipped.

Certain customer transactions include payment terms whereby we receive a partial payment of the total order amount prior to the related revenue being recognized in our financial statements. These advance payments are included in progress payments, deferred revenue and billings in excess of costs and estimated earnings in the condensed consolidated balance sheet. Generally, these progress payments relate to orders for custom equipment that require a lengthy build cycle and, in some cases, acceptance by the customer. We may negotiate payment terms with these customers on these particular orders and secure certain payments prior to or on shipment of the equipment. These payments remain in progress payments, deferred revenue and billings in excess of costs and estimated earnings until our applicable revenue recognition criteria have been met.

Certain contracts we enter into continue over an extended period of time. We review those contracts for possible revenue recognition as a long-term contract. If long-term contract accounting is appropriate, we then evaluate whether revenues should be recognized using the percentage-of-completion method. Under the percentage-of-completion method, we develop estimates as a basis for contract revenue and costs in progress as work on the contract continues. Estimates are reviewed and revised as additional information becomes available. Billings in excess of costs and earnings are included in progress payments, deferred revenue and billings in excess of costs and estimated earnings in the condensed consolidated balance sheet. The percentage-of-completion method is used in circumstances in which all the following conditions exist:

 

 

 

 

 

 

The contract includes enforceable rights regarding goods or services to be provided to the customer, the consideration to be exchanged, and the manner and terms of settlement.

 

 

Both the Company and the customer are expected to satisfy all contractual obligations; and,

 

 

Reasonably reliable estimates of total revenue, total cost, and the progress toward completion can be made.

21


We maintain an allowance for doubtful accounts based on a continuous review of customer accounts, payment patterns and specific collection issues. We perform on-going credit evaluations of our customers and do not require collateral from our customers. For many of our international customers, we require an irrevocable letter of credit from the customer before a shipment is made. If the financial condition of one or more of our customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required.

Recent Accounting Guidance Not Yet Adopted

In June 2011, the FASB issued new guidance on the presentation of comprehensive income that will require presentation of components of net income and other comprehensive income in one continuous statement or in two separate, but consecutive statements. There are no changes to the components that are recognized in net earnings or other comprehensive income under current US GAAP. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2011, with early adoption permitted. It is applicable to our fiscal periods beginning and subsequent to July 1, 2012. We are currently evaluating this guidance, but do not expect its adoption to have a material effect on our consolidated financial statements.

Adoption of New Accounting Pronouncements

In May 2011, the FASB issued guidance to amend certain measurement and disclosure requirements related to fair value measurements to improve consistency with international reporting standards. This guidance is effective prospectively for public entities for interim and annual reporting periods beginning after December 15, 2011, with early adoption by public entities prohibited, and is applicable to our fiscal periods beginning and subsequent to January 1, 2012. The adoption of this guidance did not have a material impact on our condensed consolidated financial statements.

In January 2010, the FASB issued amended standards that require additional fair value disclosures. These disclosure requirements are effective in two phases. On January 1, 2010, we adopted the requirements for disclosures about inputs and valuation techniques used to measure fair value as well as disclosures about significant transfers. The adoption of this portion of the guidance did not have a material impact on our condensed consolidated financial statements. On July 1, 2011 we adopted the requirements for disclosures concerning the presentation of disaggregated activity within the reconciliation for fair value measurements using significant unobservable inputs (Level 3). The adoption of the balance of these amended standards did not have a material impact on our condensed consolidated financial statements.

In December 2010, the FASB also issued guidance to clarify the reporting of pro forma financial information related to business combinations of public entities and to expand certain supplemental pro forma disclosures. This guidance is effective prospectively for business combinations that occur on or after the beginning of a fiscal year beginning on or after December 15, 2010, with early adoption permitted. It was applicable to our fiscal year beginning July 1, 2011. The adoption of this guidance did not have a material impact on our condensed consolidated financial statements.

22


RESULTS OF OPERATIONS

Net Revenues by Segment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal 2012

 

Fiscal 2011

 

 

 


 


 

(Dollars in millions)

 

Amount

 

Percentage
of Total

 

Amount

 

Percentage
of Total

 


 


 


 


 


 

Quarter ended March 31

 

 

 

 

 

 

 

 

 

 

 

 

 

Metrology Solutions

 

$

24.2

 

 

63

%

$

22.5

 

 

56

%

Optical Systems

 

 

14.3

 

 

37

%

 

17.7

 

 

44

%

 

 



 



 



 



 

Total

 

$

38.5

 

 

100

%

$

40.2

 

 

100

%

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine months ended March 31

 

 

 

 

 

 

 

 

 

 

 

 

 

Metrology Solutions

 

$

79.5

 

 

65

%

$

66.9

 

 

62

%

Optical Systems

 

 

43.0

 

 

35

%

 

40.5

 

 

38

%

 

 



 



 



 



 

Total

 

$

122.5

 

 

100

%

$

107.4

 

 

100

%

 

 



 



 



 



 

Net revenues for the three months ended March 31, 2012 decreased $1.7 million, or 4%, compared with the prior year period, reflecting decreases in the Optical Systems segment revenues of 19%, partially offset by an increase in the Metrology Solutions segment revenues of 8%. The decrease in the Optical Systems segment revenues was primarily due to volume decreases of $2.3 million within our optical components and EPO groups of which $1.2 million generally related to the decline in semiconductor capital market expenditures. We also saw a decrease in contract manufacturing revenues of $1.2 million as we transition from recently completed orders to production of new products. The increase in Metrology Solutions segment net revenues of $1.7 million was primarily due to a volume increase in instruments of $4.5 million, partially offset by a decrease in lithography revenues of $2.2 million. The instrument revenue increase included growth in our China region of $2.6 million. The decrease in lithography revenues continues to be attributable to the decline in semiconductor capital market expenditures.

Net revenues for the nine months ended March 31, 2012 increased 14% compared with the prior year period, reflecting increases in Metrology Solutions segment revenues of 19% and Optical Systems segment revenues of 6%. The increase in Metrology Solutions segment net revenues was primarily due to volume increases in instruments of $12.8 million and OEM heads of $2.2 million, partially offset by volume decreases in lithography revenues of $2.3 million. The China region contributed $7.2 million to the increased instruments net revenue on a year over year basis. The increase in the Optical Systems segment revenues was primarily due to an increase of $6.5 million of revenue from our EPO group, which was in operation for the full nine-month period, compared with 4½ months in the prior year period. This increase was partially offset by a $2.3 million decrease in contract manufacturing, primarily product mix, associated with the completion in fiscal 2011 of a large order for Advance Helmet Mounted Display units and volume decreases in optical components of $1.7 million.

Revenues from two customers accounted for 13% and 10% of the net revenues for the three months ended March 31, 2012 (revenues from two customers accounted for 11% each of the net revenues for the nine months ended March 31, 2012). Revenues from two customers accounted for 16% and 11% of the net revenues for the three months ended March 31, 2011 (revenues from one customer accounted for 12% of net revenues for the nine months ended March 31, 2011). Revenues from these customers were included in both of our segments.

Revenues in U.S. dollars for the three months ended March 31, 2012 and 2011 were 80% of total net revenues. Revenues in U.S. dollars for the nine months ended March 31, 2012 and 2011 were 81% and 75% of total net revenues, respectively. The balance of revenue was denominated in Euro, Yen and Yuan. Revenues based in foreign currency are exposed to foreign exchange fluctuations from the time customers are invoiced in foreign currency until collection occurs. Significant changes in the values of foreign currencies relative to the value of the U.S. dollar, or in the general economic conditions in our export markets, could materially impact the revenues of our products in these markets and our condensed consolidated financial position and results of operations.

23


Gross Margin by Segment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal 2012

 

Fiscal 2011

 

 

 


 


 

 

(Dollars in millions)

 

Gross Profit

 

Gross Margin

 

Gross Profit

 

Gross Margin

 


 


 


 


 


 

Quarter ended March 31

 

 

 

 

 

 

 

 

 

 

 

 

 

Metrology Solutions

 

$

14.0

 

 

58

%

$

12.4

 

 

55

%

Optical Systems

 

 

5.4

 

 

38

%

 

6.5

 

 

37

%

 

 



 



 



 



 

Total

 

$

19.4

 

 

51

%

$

18.9

 

 

47

%

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine months ended March 31

 

 

 

 

 

 

 

 

 

 

 

 

 

Metrology Solutions

 

$

46.5

 

 

58

%

$

37.1

 

 

55

%

Optical Systems

 

 

14.2

 

 

33

%

 

12.9

 

 

32

%

 

 



 



 



 



 

Total

 

$

60.7

 

 

50

%

$

50.0

 

 

47

%

 

 



 



 



 



 

Gross margin for the three months ended March 31, 2012 was 51%, which represents an increase of four percentage points from the comparable prior year period. Within the Metrology Solutions segment, the increase in gross margin for the three months ended March 31, 2012 compared with the prior year period was primarily due to increased volume and favorable product mix toward higher margin products within the instruments business compared with the prior year, on a similar overhead cost base. The gross margin of the Optical Systems segment for the three months ended March 31, 2012 increased by one percentage point compared with the prior year period, primarily due to better utilization of resources across all product lines. We continue to apply lean manufacturing initiatives in an effort to improve our manufacturing operations.

Gross margin for the nine months ended March 31, 2012 was 50%, which represents an increase of three percentage points from the comparable prior year period. Within the Metrology Solutions segment, the increase in gross margin for the nine months ended March 31, 2012 compared with the prior year period was primarily due to increased volume and favorable product mix within the instruments business due to a number of large custom systems during the current nine month period compared with the prior year. Gross margin of the Optical Systems segment for the nine months ended March 31, 2012 increased by one percentage point compared with the prior year period, primarily through increased efficiencies in our optical components factory and increased volume from our EPO group, which was in operation for the full nine month period, compared with 4 ½ months in the prior year period.

Selling, General and Administrative Expenses (“SG&A”)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal 2012

 

Fiscal 2011

 

 

 


 


 

(Dollars in millions)

 

Amount

 

Percentage of
Net Revenues

 

Amount

 

Percentage of
Net Revenues

 


 


 


 


 


 

 

Quarter ended March 31

 

$

8.7

 

 

23

%

$

9.4

 

 

23

%

Nine months ended March 31

 

$

26.3

 

 

21

%

$

24.9

 

 

23

%

SG&A decreased in the three months ended March 31, 2012 by $0.7 million from the comparable prior year period. The decrease was primarily due to a decrease in employee benefit costs related to performance-based compensation programs, partially offset by an increase in salaries and wages related to increased headcount.

SG&A increased in the nine months ended March 31, 2012 by $1.4 million from the comparable prior year period. The increase was primarily due to employee compensation expenses related to increased headcount, which accounted for $1.8 million, increased selling and commission expenses of $0.6 million, and increases in certain employee benefits of $1.0 million, partially offset by decrease in employee benefit costs related to performance-based compensation programs and the absence in the current year of acquisition related expenses.

24


Research, Development and Engineering Expenses (“RD&E”)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal 2012

 

Fiscal 2011

 

 

 


 


 

(Dollars in millions)

 

Amount

 

Percentage of
Net Revenues

 

Amount

 

Percentage of
Net Revenues

 


 


 


 


 


 

 

Quarter ended March 31

 

$

4.0

 

 

10

%

$

3.7

 

 

9

%

Nine months ended March 31

 

$

12.2

 

 

10

%

$

10.9

 

 

10

%

RD&E for the three months ended March 31, 2012 increased by $0.3 million compared with the prior year period. The increase was primarily due to the increases in spending in our lithography product line. RD&E spending was relatively stable for both quarters at 10% and 9% of net revenues for fiscal 2012 and 2011, respectively.

RD&E for the nine months ended March 31, 2012 increased by $1.3 million compared with the prior year period. The increase was primarily due to spending in our lithography product line and EPO group. Overall, spending as a percentage of net revenues was relatively unchanged at 10% for the nine months ended March 31, 2012 and 2011.

Other Income (Expense)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal 2012

 

Fiscal 2011

 

 

 


 


 

(Dollars in millions)

 

Amount

 

 

Percentage of
Net Revenues

 

Amount

 

Percentage of
Net Revenues

 


 


 

 


 


 


 

 

Quarter ended March 31

 

$

 

 

0

%

$

(0.2

)

 

0

%

Nine months ended March 31

 

$

(0.2

)

 

0

%

$

1.4

 

 

1

%

Other income (expense) for the nine months ended March 31, 2011 included a gain on acquisition of $1.3 million. Other income (expense) for the three and nine months ended March 31, 2012 includes $0.1 million and $0.4 million, respectively, that was recorded as interest expense on the payment of the future consideration as part of the acquisition.

Income Tax Expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal 2012

 

Fiscal 2011

 

 

 


 


 

(Dollars in millions)

 

Amount

 

Tax Rate %

 

Amount

 

Tax Rate %

 


 


 


 


 


 

 

Quarter ended March 31

 

$

0.8

 

 

12

%

$

0.7

 

 

13

%

Nine months ended March 31

 

$

2.4

 

 

11

%

$

1.5

 

 

9

%

Income tax expense for the three and nine months ended March 31, 2012 and 2011 included income taxes in state and foreign jurisdictions. The effective tax rate is lower than the statutory United States (“U.S.”) rate due to no U.S. federal income tax expense for the three and nine months ended March 31, 2012 and 2011 as a result of having valuation allowances on net deferred tax assets, including net operating loss carry-forwards in the United States. Income tax expense for the nine months ended March 31, 2011 also included an income tax benefit of $0.7 million from an adjustment of valuation allowances on our net deferred tax assets associated with the Richmond asset acquisition.

In fiscal 2009, we established a valuation allowance against substantially all our net deferred tax assets based upon the consideration of all available evidence. As of March 31, 2012, we have concluded that we should continue to maintain valuation allowances on substantially all of our net deferred tax assets. In future periods, the valuation allowances could be reduced based upon sufficient evidence indicating that it is more likely than not that a portion of the net deferred tax assets will be realized.

25


TRANSACTIONS WITH STOCKHOLDER

Revenues from Canon Inc., a stockholder, and Canon Sales Co., Inc., a distributor of certain of our products in Japan and a subsidiary of Canon Inc. (collectively referred to as “Canon”), amounted to $5.0 million and $6.4 million (13% and 16% of net revenues, respectively) for the three months ended March 31, 2012 and 2011, respectively. For the nine months ended March 31, 2012 and 2011, sales to Canon amounted to $14.0 million and $13.4 million (11% and 12% of net revenue, respectively.) Selling prices of products sold to Canon are based, generally, on the terms customarily given to distributors. At March 31, 2012 and June 30, 2011, there were, in the aggregate, $1.3 million and $2.6 million, respectively, of trade accounts receivable from Canon.

LIQUIDITY AND CAPITAL RESOURCES

We assess our liquidity in terms of our ability to generate cash to fund our operating, investing and financing activities. Our principal source of liquidity is our cash reserves and operating cash flows. In addition to operating cash flows, other significant factors that affect our overall management of liquidity include: capital expenditures, customer credit requirements, investments in businesses and the availability of bank lines of credit.

At March 31, 2012, cash and cash equivalents were $89.3 million, an increase of $28.3 million from $61.0 million at June 30, 2011, of which $16.3 million is located in foreign jurisdictions subject to repatriation regulations. The cash balance in our money market account, that is invested primarily in U.S. government securities, was $19.9 million as of March 31, 2012. We do not believe there is any risk to liquidity in the money market account, nor are there currently any limits on redemptions.

Cash provided by operating activities from continuing operations for the nine months ended March 31, 2012 of $31.1 million was primarily due to net earnings and reductions in accounts receivable. Accounts receivable decreased $8.0 million from June 30, 2011 and $4.0 million from December 31, 2011. Days sales outstanding on accounts receivable decreased to 53 days at March 31, 2012 compared to 58 days at December 31, 2011 and 63 days at June 30, 2011 primarily due to collection activities, including a reduction of overdue balances and the application of progress payments.

Cash used for investing activities for the nine months ended March 31, 2012 of $1.6 million was related to the purchase of property, plant and equipment ($2.5 million), partially offset by the proceeds from the maturity and sale of marketable securities ($1.1 million, net).

Cash provided by financing activities in the nine months ended March 31, 2012 was $0.7 million. For the nine months ended March 31, 2012, there were $2.9 million in proceeds from stock option exercises, partially offset by dividend payments of $2.2 million to noncontrolling interests.

We currently have no lines of credit. In the future, if the need for debt or credit lines arises, there is no assurance that we would be able to secure such financing. We believe we have sufficient cash flows from operations and cash reserves to maintain adequate amounts of liquidity and to meet our future liquidity requirements for at least the next twelve months.

26


OFF-BALANCE SHEET ARRANGEMENTS

We have not created, and are not party to, any special-purpose or off-balance sheet entities for the purpose of raising capital, incurring debt, or operating parts of our business that are not consolidated into our financial statements. We have not guaranteed any obligations of a third party.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

There have been no material changes in our quantitative and qualitative market risk disclosures during the three months ended March 31, 2012. Please refer to Item 7a., “Quantitative and Qualitative Disclosures about Market Risk,” of our Annual Report on Form 10-K for the year ended June 30, 2011, filed with the Securities and Exchange Commission (the “2011 Annual Report”) for a discussion of our exposure to market risk.

Item 4. Controls and Procedures

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, carried out an evaluation, as of the end of the period covered by this report, of the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based upon their evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of the end of such period, our disclosure controls and procedures were effective.

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred in our most recent fiscal quarter that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

27


PART II - Other Information

Item 1A. Risk Factors

Part I, “Item 1A. Risk Factors” in our 2011 Annual Report includes a listing of risk factors that could materially affect our business, financial condition, or future results. There have been no material changes in our risk factors from those set forth in our 2011 Annual Report; however, the risks described in our 2011 Annual Report are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The following table provides information about our purchases during the quarter ended March 31, 2012, of equity securities that are registered by us pursuant to Section 12 of the Securities Exchange Act of 1934.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Period

 

Total number of
shares purchased

 

Average price
paid per share

 

Total number of
shares purchased as
part of publicly
announced
plans or programs (1)

 

Approximate dollar
value of shares that
may yet be purchased
under the plans or
programs (in millions)

 


 


 


 


 


 

 

January 1, 2012 - January 31, 2012

 

 

5,898

 

$

16.93

 

 

 

$

5.0

 

February 1, 2012 - February 29, 2012

 

 

 

 

n/a

 

 

 

$

5.0

 

March 1, 2012 - March 31, 2012

 

 

 

 

n/a

 

 

 

$

5.0

 


 

 

 

 

(1)

In August 2007, our Board of Directors authorized the repurchase of up to $25.0 million of our outstanding common stock. During the three months ended March 31, 2012, there were no repurchases of common stock in the open market. These historical share repurchases have been effected pursuant to plans in conformity with Rule 10b5-1 under the Securities Exchange Act of 1934. This rule allows public companies to adopt written, pre-arranged stock trading plans when they do not have material, non-public information in their possession. The adoption of this stock trading plan allows us to repurchase our shares during periods when we otherwise might be prevented from doing so under insider trading laws or because of self-imposed trading blackout periods.

28


Item 6. Exhibits

 

 

 

(a)

Exhibits:

 

 

 

31.1

Certification Pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, As Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

31.2

Certification Pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, As Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

32.1

Certification Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

32.2

Certification Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

101.INS*   XBRL Instance Document

 

 

 

101.SCH*  XBRL Taxonomy Extension

 

 

 

101.CAL*  XBRL Taxonomy Extension Calculation Linkbase

 

 

 

101.DEF*  XBRL Taxonomy Extension Definition Linkbase

 

 

 

101.LAB*  XBRL Taxonomy Extension Label Linkbase

 

 

 

101.PRE*  XBRL Taxonomy Extension Presentation Linkbase

*Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, or Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.

29


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

 

     Zygo Corporation

 

 


 

 

     (Registrant)

 


 

 

 

 

/s/ Chris L. Koliopoulos

 

 


 

 

Chris L. Koliopoulos

 

President and Chief Executive Officer


 

 

 

 

/s/ John P. Jordan

 

 


 

 

John P. Jordan

 

 

Vice President, Chief Financial Officer and Treasurer

Date: May 10, 2012

30


EXHIBIT INDEX

 

 

 

 

31.1

Certification Pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, As Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

31.2

Certification Pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, As Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

32.1

Certification Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

32.2

Certification Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

101.INS*   XBRL Instance Document

 

 

 

101.SCH*  XBRL Taxonomy Extension

 

 

 

101.CAL*  XBRL Taxonomy Extension Calculation Linkbase

 

 

 

101.DEF*  XBRL Taxonomy Extension Definition Linkbase

 

 

 

101.LAB*  XBRL Taxonomy Extension Label Linkbase

 

 

 

101.PRE*  XBRL Taxonomy Extension Presentation Linkbase


 

 

 

*Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, or Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.